Karlsson Gudiol Georgala icaac 2012 finalprogram web4a

111 MONDAY SCIENTIFIC SESSIONS Final Program T-1031 Refractory KPC Carbapenemase-Producing Klebsiella pneumoniae Bacteremia is Tolerated by Solid Organ Transplant Patients SOT Pts

C. Clancy

1 , R. K. Shields 2 , Y. Zhao 3 , L. Chen 3 , B. N. Kreiswirth 3 , E. J. Kwak 2 , F. Silveira 2 , K. Abu-Elmagd 2 , G. Costa 2 , M. Nguyen 2 ; 1 Univ. of Pittsburgh and VA Pittsburgh, Pittsburgh, PA, 2 Univ. of Pittsburgh, Pitts- burgh, PA, 3 Publ. Hlth. Res. Ins., UMDNJ, Newark, NJ. T-1032 Comparison of Three Methods for Detection of Latent TB in Solid Organ Transplant Candidates

S. Kusne

1 , T. M. Seville 1 , H. R. Vikram 1 , Y. H. Chang 1 , A. E. McCullough 1 , M. J. Binnicker 2 , J. E. Blair 1 ; 1 Mayo Clinic Arizona, Phoenix, AZ, 2 Mayo Clinic Rochester, Rochester, MN. T-1033 Prevalence and Epidemiology of Positive QuantiFERON among Pre-Kidney Transplant Recipients

J. Simkins, M. I. Morris; Univ. of Miami, Miller Sch. of Med., Miami, FL. T-1034

Epidemiology and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae CRKP Bacteriuria in Renal Transplant RT Recipients

S. M. Pouch

1,2 , C. J. Kubin 1,2 , D. Tsapepas 1 , G. Dube 2 , M. Pereira 2 ; 1 NewYork-Presbyterian Hosp., New York, NY, 2 Columbia Univ. Med. Ctr., New York, NY. T-1035 Extended Spectrum Beta Lactamase-Producing Enterobacte- riaceae Associated Infections in Kidney Transplant Recipients: A Case-Control Study E. Righi, M. Giannella, M. L. Balsamo, A. Colombo, D. Donati, A. Curto, N. Astuti, A. Tebini Project Leader, P. A. Grossi; Insubria Univ., Varese, Italy. T-1036 Epidemiology and Antimicrobial Resistance in Urine Isolates Among Renal Transplant Recipients Over a 10-Year Period

C. J. Kubin

1,2 , S. M. Pouch 1 , D. Tsapepas 1 , G. Dube 2 , M. Pereira 2 ; 1 New York Presbyterian Hosp., New York, NY, 2 Columbia Univ., New York, NY. T-1037 Clinical and Molecular Epidemiologic Characterization of Methicillin-Resistant Staphylococcus aureus MRSA Infections Occurring Early after Lung Transplant LTx M. Nguyen 1 , M. Shelton, BA 1 , R. K. Shields 1 , J. Marsh 1 , L. H. Har- rison 1 , E. J. Kwak 1 , F. Silveira 1 , Y. Toyoda 1 , N. Shigemura 1 , C. Bermudez, M.D. 2 , C. Clancy 2 ; 1 Univ. of Pittsburgh, Pittsburgh, PA, 2 Univ. of Pittsburgh and VA Pittsburgh, Pittsburgh, PA. T-1038 Low Incidence of Bacterial Resistance and Mortality in the New Era of Haematopoietic Stem Cell Transplantation

L. Yañez, A. Bermudez, A. Insunza; Hosp. Univ. Marques De Valdecilla, Santander, Spain.

T-1039 Vancomycin-Resistant Enterococcus VRE Bacteremia in Immunocompromised Patients

Y. L. Song, J. I. Ito, B. Tegtmeier, S. S. Dadwal, J. Kriengkauykiat; City of Hope, Duarte, CA.

T-1040 Risk Factors for Bacterial Infection After Liver Transplanta- tion: A Retrospective Study in 195 Patients from Four Centers in Central Italy L. Tessitore, P. Piselli, M. Giannella, M. Antonini, L. Sollazzi, M. Dauri, F. Pugliese, V. Perilli, M. Polzoni, F. Ruperto, V. Puro, N. Petrosillo 2nd Divi- sion, on behalf of the NETWORK group; INMI L. Spallanzani, Rome, Italy. T-1041 Pneumonia after Solid Organ Transplantation: A Multicenter Prospective Study

M. Giannella

1 , P. Munoz 1 , J. Martinez Alarcon 2 , P. Grossi 3 , E. Bouza 1 , on behalf of the PISOT Study Group; 1 Hosp. Gregorio Maranon, Madrid, Spain, 2 Hosp. de Ciudad Real, Ciudad Real, Spain, 3 Univ. of Insubria, Varese, Italy. T-1042 Opsonophagocytic Activity of Pneumococcal Antibodies in Vaccinated Patients with B-Cell Malignancies

J. Karlsson

1,2 , H. Hogevik 3 , K. Andersson 2 , B. Andréasson 4 , C. Wennerås 2,5 ; 1 Infectious Diseases, TrollhättanUddevalla, Sweden, 2 Clinical Bacteriology, Göteborg, Sweden, 3 Dev., TrollhättanUddevalla, Sweden, 4 HematologyIn- ternal Med., TrollhättanUddevalla, Sweden, 5 Hematology and Coagulation, Göteborg, Sweden. T-1043 Incidence and Burden of Infection-Related Hospitalizations among Solid-Organ Transplant Recipients B. Hamandi, A. Morillo, C. Rotstein, L. G. Singer, E. Renner, S. J. Kim, H. Ross, S. Husain; Univ. Hlth. Network, Toronto, Canada. T-1044 Infectious Complications of Central Venous Catheters in Patients Undergoing Hematopoietic Stem Cell Transplantation G. Martinho, R. Romanelli, G. Teixeira, J. Chaia, A. Macedo, W. Trindade , V. Nobre; Univ. Federal de Minas Gerais, Belo Horizonte, Brazil. T-1045 Current Clinical Features and Outcomes of Early-Onset and Late-Onset Bloodstream Infection BSI in Hematopoietic Stem Cell Transplant HSCT Recipients

C. Gudiol

1 , C. Garcia-Vidal 1 , M. Cisnal 1 , M. Arnan 2 , I. Sánchez-Ortega 2 , R. Duarte 2 , J. Carratalà 1 ; 1 Hosp. Univ. de Bellvitge, Barcelona, Spain, 2 Hosp. Duran i Reynals, Barcelona, Spain. T-1046 Surveillance Cultures SC and Microbiological Documenta- tion of “Bad Bugs” Among Hematological Patients HP Present- ing Febrile Neutropenia FN

A. Georgala

1 , A. Dediste 2 , M. Paesmans 1 , M. Aoun 1 ; 1 Inst. Jules Bordet, Bruxelles, Belgium, 2 Lab. de la Porte de Hal CHU St Pierre-Inst. Jules Bordet, Bruxelles, Belgium. Late-breaker presentations are listed behind the Late-breaker tab of the Final Program. 112 SCIENTIFIC SESSIONS September 9-12 | ------------------------------------------------------------------------ 114 G Slide Session Vaccines: Innovations, Impact and Safety Monday, 1:30 p.m.–4:00 p.m. . . . . . . . . . . . . . . . . . . . Room 121 UAN: 0391-9999-12-086-L04-P Moderators: Jan Bonhoeffer, MD - Assistant Professor Infectious Disease and Vaccines, Univ. Children’s Hosp., Basel, Switzerland. Penina Haber, MPH - Epidemiologist Immunization safety, CDC, Atlanta, GA. Objectives: Upon the completion of this Slide Session, the participant should be able to: Highlight new vaccine developments; Provide updated information on vaccine impact and safety; and Discuss the impact of newer vaccines. Presentations: 1:30 p.m. G-1047 Antibody Persistence and the Effect of a Booster Dose Given 5, 10 or 15 Years After Vaccination With a Recombinant Hepatitis B Vaccine V. Gilca, MD, PhD - Medical Epidemiologist 1,2,3 , N. Boulianne, MS - Medi- cal Epidemiologist 1,2,3 , M. Dionne, MD - Scientific Director 1,2,3 , P. D. Wals, MD, PhD - Medical Epidemiologist 1,2,3 , G. D. Serres, MD, PhD - Medical Epidemiologist 1,2,3 ; 1 Quebec Publ. Hlth. Inst., Quebec, Canada, 2 Laval Univ. Res. Hosp. Ctr., Quebec, Canada, 3 Laval Univ., Quebec, Canada. 1:45 p.m. G-1048 Safety and Immunogenicity of an Intramuscular Bivalent Norovirus VLP Vaccine J. J. Treanor, MD - Prof Med